- Benzinga•9 hours ago
On Friday, the Vetr crowd upgraded their rating for Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) from its previous position at 1 star (Strong Sell) issued 88 days ago, to 4.5 star (Strong Buy). Crowd ...
- Business Wire•yesterday
Alnylam Pharmaceuticals, Inc. , the leading RNAi therapeutics company, announced today that it will webcast its upcoming R&D Day, including a live video stream, on the Investors section of the company’s website, www.alnylam.com, on the morning of December 16, 2016.
- Motley Fool•3 days ago
Alnylam Pharmaceuticals rebounded in a big way last month.
ALNY : Summary for Alnylam Pharmaceuticals, Inc. - Yahoo Finance
Alnylam Pharmaceuticals, Inc. (ALNY)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
|Bid||35.00 x 200|
|Ask||43.14 x 100|
|Day's Range||41.12 - 43.57|
|52 Week Range||31.38 - 98.00|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-9.30|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|